Insights

Lupin Implements Acceliant Platform for BA/BE studies

Lupin Implements Acceliant Platform for BA/BE studies

Objective- Lupin was looking for a robust platform for their clinical studies which has a best in breed user interface and is also cost effective. Major challenges:-

07 Jul 2017

Acceliant Transforms one of the largest eClinical Studies

Acceliant Transforms one of the largest eClinical Studies

Objective A leading Fortune 500 pharma multinational in US was looking for an EDC solution for their late phase Immunology and infectious disease TA. Since the quantum of trial Parameter was enormous, the client wanted to have a platform which can be scalable quickly as the trial progresses. Benefits Acceliant helped by:-

07 Jul 2017

CONTACT US TODAY

Watch: How we add value

Want to know more? Talk to us.

Contact us+1-408-387-5800